Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652650 | SCV000774521 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2W | 2024-10-28 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 316 of the LIMS2 protein (p.Asn316Lys). This variant is present in population databases (rs149101001, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with LIMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 542250). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt LIMS2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000652650 | SCV003814630 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2W | 2023-08-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692045 | SCV005187903 | uncertain significance | not provided | criteria provided, single submitter | not provided |